Virus News and Research

Latest Virus News and Research

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Scientists have recently used synthetic biology to design primary human CD8 T cells to express Spike protein-specific chimeric antigen receptors (ACE2 CAR or anti-Spike CAR).

25 Jan 2022

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

A new study has focused on the identification, in vitro binding, and potent neutralizing activity of STI-9167 (plutavimab) against live viruses and pseudotype viruses.

25 Jan 2022

Impact of a third BNT162b2 dose on SARS-CoV-2 Omicron variant

In a new study, researchers assessed the extent and duration of the neutralization of SARS-CoV-2 Omicron variant of concern after the administration of two and three doses of the BNT162b2 mRNA vaccine.

25 Jan 2022

Study opens the door to a new approach to attacking herpesviruses

A new study published this week in mBio, an open access journal of the American Society for Microbiology, has opened the door to a new approach to attacking herpesviruses.

25 Jan 2022

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

A new preprint available on medRxiv* demonstrates the marked improvement in the immune response when the mRNA vaccine BNT162b2, from Pfizer/BioNTech, is used for the third dose after a primary two-dose series of an inactivated whole virus vaccine.

25 Jan 2022

Evaluation of cross-reactive T cell responses between SARS-CoV-2 and common-cold human coronaviruses

A new study investigated SARS-CoV-2 spike protein responses targeted by cross-reactive T cells that were isolated from convalescent COVID-19 individuals along with previously uninfected donors.

25 Jan 2022

FFP2 respirator masks provide superior protection from Covid-19 than cloth masks

As the UK lifts the legal requirement for face masks in most indoor public areas in England, new research from the University of Surrey and the University of Bristol has shown that FFP2 (filtering facepiece) respirator masks are typically five times more efficient at filtering particles which carry the Covid-19 virus than cloth masks.

25 Jan 2022

Study explores individuals’ experiences with long COVID

The current study sought to present the actual face of the condition in experiential terms.

25 Jan 2022

Protection against SARS-CoV-2 Omicron afforded by Pfizer-BioNTech and Moderna boosters compared to two-dose primary series

The current paper compares the effectiveness of two vs. three doses of these vaccines against Omicron compared to Delta.

25 Jan 2022

Scientists develop a model to rapidly identify vaccine breakthrough SARS-CoV-2 variants

In a new study, scientists have recently developed a computational model to predict the antigenicity and immune escape ability of emerging variants of SARS-CoV-2.

25 Jan 2022

New data reveals increase in shark bites after three years of decline

After three consecutive years of worldwide declines, the number of shark bites picked up in 2021, with a total of 73 unprovoked incidents. The data, published this week by the Florida Museum of Natural History's International Shark Attack File, also included 39 provoked shark bites and nine fatalities that occurred throughout the year.

25 Jan 2022

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

In a new study, exhaled aerosols were compared between infected SARS-CoV-2 patients and healthy controls for the first time. A preprint version of this study, which is yet to undergo peer review, is available on the medRxiv* server.

24 Jan 2022

Neurological complications of the SARS-CoV-2 vaccine

In a study published in the latest issue of the journal Neurological Sciences, a team of researchers described a three-patient case series presenting with neurological manifestations after the coronavirus disease 2019 (COVID-19) vaccination, followed by a literature review, to propose hypotheses on how neurological symptoms might develop after vaccination.

24 Jan 2022

Current vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 variants

Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2.

24 Jan 2022

Eligible adults urged to take part in world-first COVID-19 study of antivirals

Adults over the age of 50 or with an underlying health condition who test positive for COVID-19 are being urged to sign up for a world-first COVID-19 study which is providing life-saving antivirals to thousands of people.

24 Jan 2022

Study could offer a novel strategy to fight respiratory syncytial virus and coronaviruses

A new approach that targets the cellular machinery that viruses need to reproduce – rather than the virus itself – appears to stem replication of a common childhood pathogen known as respiratory syncytial virus (RSV), UT Southwestern researchers report in a new study.

24 Jan 2022

New, low-cost COVID-19 test could make high-performance testing more accessible

Researchers at the University of Washington have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests that are processed in medical labs and hospitals.

24 Jan 2022

Constructing SARS-CoV-2 virus-like particles in tobacco plants for vaccine development

In a study published in the latest issue of the Scientific Reports, a team of researchers constructed virus-like particles (VLPs) composed of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M), envelope (E), and nucleocapsid (N) proteins in tobacco plant using Agrobacterium-mediated delivery.

24 Jan 2022

Study finds a sharp dip in access to care for poorer Americans during the pandemic

Americans' use of common outpatient health services dipped sharply at the outset of the COVID-19 pandemic, then rebounded to near-normal levels by the end of 2020, only to decline again during the second surge in January–February 2021, according to a new UCLA-led study.

24 Jan 2022

Experts issue new CPR guidance addressing highly contagious variants of SARS-CoV-2

In response to the COVID-19 pandemic, the American Heart Association and collaborating organizations, including the American Academy of Pediatrics, the American Association for Respiratory Care, the Society of Critical Care Anesthesiologists and the American Society of Anesthesiologists, continue to provide interim guidance to address the latest scientific research related to the SARS-CoV-2 virus, particularly the Delta and Omicron variants.

24 Jan 2022

Virus News and Research

Latest Virus News and Research

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

Impact of a third BNT162b2 dose on SARS-CoV-2 Omicron variant

Study opens the door to a new approach to attacking herpesviruses

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

Evaluation of cross-reactive T cell responses between SARS-CoV-2 and common-cold human coronaviruses

FFP2 respirator masks provide superior protection from Covid-19 than cloth masks

Study explores individuals’ experiences with long COVID

Protection against SARS-CoV-2 Omicron afforded by Pfizer-BioNTech and Moderna boosters compared to two-dose primary series

Scientists develop a model to rapidly identify vaccine breakthrough SARS-CoV-2 variants

New data reveals increase in shark bites after three years of decline

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

Neurological complications of the SARS-CoV-2 vaccine

Current vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 variants

Eligible adults urged to take part in world-first COVID-19 study of antivirals

Study could offer a novel strategy to fight respiratory syncytial virus and coronaviruses

New, low-cost COVID-19 test could make high-performance testing more accessible

Constructing SARS-CoV-2 virus-like particles in tobacco plants for vaccine development

Study finds a sharp dip in access to care for poorer Americans during the pandemic

Experts issue new CPR guidance addressing highly contagious variants of SARS-CoV-2

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in